These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 90549)

  • 1. Comparative effects of lignocaine and lorcainide on conduction in the Langendorff-perfused guinea-pig heart.
    Carmeliet E; Zaman MY
    Cardiovasc Res; 1979 Aug; 13(8):439-49. PubMed ID: 90549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of S-1389 (711389-S), a new antiarrhythmic agent, on the conduction in perfused guinea pig hearts.
    Ninomiya M; Tani T; Ueda M
    Jpn J Pharmacol; 1989 Dec; 51(4):555-62. PubMed ID: 2615048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of SUN 1165, a new potent antiarrhythmic agent, on the kinetics of rate-dependent block of Na channels and ventricular conduction of extrasystoles.
    Hattori Y; Hidaka T; Aisaka K; Satoh F; Ishihara T
    J Cardiovasc Pharmacol; 1988 Apr; 11(4):407-12. PubMed ID: 2453743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrillatory efficacy of encainide, loracainide and ORG 6001 compared with lignocaine in isolated hearts of rabbits and guinea-pigs.
    Almotrefi AA; Baker JB
    Br J Pharmacol; 1981 Jun; 73(2):373-7. PubMed ID: 6786403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of duration of rapid ventricular pacing on ventricular refractoriness in the presence of propafenone and lidocaine.
    Stark U; Stark G; Kasper K; Schwarzl I; Decrinis M; Pilger E; Tritthart HA
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):43-50. PubMed ID: 9121970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of OPC-88117, a new antiarrhythmic agent, on the electrophysiological properties of rabbit isolated hearts.
    Nezasa Y; Kodama I; Toyama J
    Br J Pharmacol; 1989 Sep; 98(1):186-91. PubMed ID: 2553187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Electrophysiologic effects of lorcainide (R 15889) in man].
    Touboul P; Atallah G; Kirkorian G
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1333-40. PubMed ID: 6797372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracardiac electrophysiological effects of lorcainide in man.
    Ng CK; Gstöttner M; Gmeiner R
    Eur J Clin Pharmacol; 1979 May; 15(4):241-7. PubMed ID: 477708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological actions of lorcainide in patients with cardiac disease.
    Kasper W; Meinertz T; Kersting F; Löllgen H; Lang K; Just H
    J Cardiovasc Pharmacol; 1979; 1(3):343-52. PubMed ID: 94401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological effects of lorcainide, a new antiarrhythmic drug. Observations in patients with and without pre-excitation.
    Bär FW; Farré J; Ross D; Vanagt EJ; Gorgels AP; Wellens HJ
    Br Heart J; 1981 Mar; 45(3):292-8. PubMed ID: 7470342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical electrophysiologic effects of lorcainide in patients and its effect on the conduction of accessory pathway in Wolff-Parkinson-White syndrome].
    Jiang H
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Jun; 18(3):157-9, 190. PubMed ID: 2086169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Change in impulse formation and impulse transmission of the heart in relation to high magnesium concentration].
    Stark G; Stark U; Pilger E; Hönigl K; Bertuch H; Tritthart HA
    Wien Med Wochenschr; 1988 Aug; 138(15-16):379-81. PubMed ID: 3176509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A specific effect of lidocaine and tocainide on ventricular conduction of mid-range extrasystoles.
    Man RY; Dresel PE
    J Cardiovasc Pharmacol; 1979; 1(3):329-42. PubMed ID: 94400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of elevated Mg2+ concentrations on cardiac electrophysiologic parameters.
    Stark G; Stark U; Pilger E; Hönigl K; Bertuch H; Tritthart HA
    Cardiovasc Drugs Ther; 1989 Apr; 3(2):183-9. PubMed ID: 2484855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic, electrophysiologic and hemodynamic effects of lorcainide.
    Carmeliet E; Janssen PA; Marsboom R; Van Nueten JM; Xhonneux R
    Arch Int Pharmacodyn Ther; 1978 Jan; 231(1):104-30. PubMed ID: 637616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological effects of a new antiarrhythmic agent, lorcainide, on the isolated cardiac muscle fiber as compared with disopyramide.
    Shigenobu K; Atoda H; Asano T; Kasuya Y
    J Pharmacobiodyn; 1980 Dec; 3(12):677-85. PubMed ID: 7277183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative electrophysiology of lorcainide and norlorcainide in the dog.
    Keefe DL; Kates RE; Winkle RA
    J Cardiovasc Pharmacol; 1984; 6(5):808-15. PubMed ID: 6209484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of slowed conduction in premature ventricular beats induced during programmed stimulations in perfused guinea-pig heart.
    Osadchii OE
    Exp Physiol; 2018 Sep; 103(9):1230-1242. PubMed ID: 29956404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate-dependent effects of ajmaline and propafenone on atrioventricular conduction.
    Stark G; Schwarzl I; Stark U; Decrinis M; Tritthart HA
    Eur J Pharmacol; 1996 Aug; 310(1):29-35. PubMed ID: 8880064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of procainamide, tocainide and lorcainide on Na(+)-K(+)-ATPase in guinea pig heart preparations.
    Dzimiri N; Almotrefi AA
    Gen Pharmacol; 1991; 22(2):403-6. PubMed ID: 1647350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.